Recent research has shown that a closed-loop insulin delivery system—also known as an artificial pancreas—controls glucose more effectively than standard subcutaneous insulin therapy during hospitalization.
The investigators randomly assigned 136 adults with type 2 diabetes who needed insulin to receive it with the automated system or via standard subcutaneous therapy for 15 days or until they were discharged.
Slomski A. Automated Device Improves Glucose Control in Hospitalized Patients. JAMA. 2018;320(8):749. doi:10.1001/jama.2018.12042
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: